Ganciclovir description

Ganciclovir

VITRASERT® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Description

[edit | edit source]

The Vitrasert Implant contains the antiviral drug ganciclovir. Each Vitrasert Implant contains a minimum of 4.5 mg ganciclovir.

Each Vitrasert Implant contains a ganciclovir tablet which contains the inactive ingredient, magnesium stearate (0.25%). Each tablet is coated with polyvinyl alcohol and ethylene vinyl acetate polymers.

The chemical name of ganciclovir is 9-[[2-hydroxy -1- (hydroxymethyl)ethoxy] methyl]guanine, and has the following structure:

[1]

## References

[edit | edit source]

1. ↑ "http://www.drugbank.ca/system/fda_labels/DB01004.pdf?1265922812" (PDF). External link in `|title=` (help)

Adapted from the FDA Package Insert.